home

conference

american-academy-of-dermatology

American Academy of Dermatology 

Articles

Biologic therapy has proven very useful in treating an increasing number of dermatologic diseases and conditions. However, caution is warranted for patients with chronic infectious diseases. 

Dangers, Benefits of Biologics Must Be Carefully Weighed

New regulations, latest absorption data, and updates on environmental and health impacts are shaping the world of photoprotection. 

What’s New in Photoprotection?

Trichoscopy, which is based on dermoscopy, can be a valuable tool for diagnosing conditions that cause hair loss and inflammatory scalp disease.

Trichoscopy Advances Hair and Scalp Disease Diagnoses

John Jesitus is a medical writer based in Westminster, CO.

Dermatologists are divided over concerns of spironolactone being underused in women and patients taking isotretinoin being overmonitored. 

Spironolactone Underused, Isotretinoin Overmonitored

Podcasts

In this episode, we take a look back at what happened at the American 
Academy of Dermatology Virtual Meeting Experience 2021 (AAD VMX 2021), including exclusive interviews with two KOLs about their presentations regarding climate change and new data on biologics for psoriasis. 

The Cutaneous Connection: Episode 23- Roundup of AAD VMX 2021

Novel biologics are moving into off-label indications to expand the dermatologic armamentarium for a broad range of inflammatory skin diseases.  

Off-label Biologics Target Wide Range of Skin Diseases

Videos

In part two of our interview with Misha Rosenbach, MD, he reveals what kind of skin manifestations are on the rise due to global warming and how dermatologists can help fight against climate change.

How Can Dermatologists Help Fight Climate Change?

Misha Rosenbach, MD, discusses the effects climate change has on dermatology and how using social media can help spread awareness. 

Climate Change and its Link to Dermatology

A study at AAD VMX 2021 presented data on possible association between sex, skin cancer medication, and dermatologic adverse events. 

Relation Between Skin Cancer Medication and Dermatologic Adverse Events

New data from a phase 3 study evaluating SGX301 for treatment of cutaneous T-cell lymphoma (CTCL) skin symptoms was recently presented at the American Academy of Dermatology Virtual Meeting Experience (AAD VMX 2021).